GlassScriptPhysician profile
Mark J Kulbaski
NPI 1699756247
$6,307.12
in general payments reported to CMS, 2019-2025
25 companies · $2,499 in 2025
The $2,499 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,689 · 2020: $282 · 2021: $409 · 2022: $398 · 2023: $453 · 2024: $578 · 2025: $2,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,048 · Food and Beverage: $1,434 · Travel and Lodging: $48.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,047.50 |
| Food and Beverage | $1,433.94 |
| Travel and Lodging | $48.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $2,145.53 | 2022-2025 | Igt Systems Undivided |
| Silk Road Medical, INC. | $1,369.02 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Bard Peripheral Vascular, INC. | $520.54 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $424.28 | 2019-2023 | Xarelto |
| Smith+Nephew, INC. | $420.79 | 2022-2025 | Grafix Pl, Stravix, Grafix Xc |
| Endologix LLC | $281.73 | 2019-2023 | |
| Boston Scientific Corporation | $266.23 | 2023-2025 | Varithena Administration Pack, Peripheral Rotalink Plus, Opticross 35 |
| Humacyte Global, INC. | $138.18 | 2025 | Symvess |
| Sanara Medtech INC. | $103.63 | 2024 | Celleraterx |
| Cardiovascular Systems INC. | $78.66 | 2019 | |
| Shockwave Medical, INC | $70.91 | 2022 | |
| Bsn Medical INC | $64.73 | 2023 | |
| Abbvie INC. | $60.99 | 2025 | |
| Lemaitre Vascular, INC. | $58.31 | 2023-2025 | Artegraft Vascular Graft |
| Terumo Medical Corporation | $47.10 | 2025 | Angio-Seal, Glidewire, Glidesheath Slender |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $40.45 | 2025 | Ethicon, Enseal X1 |
| Medtronic, INC. | $37.65 | 2023 | Venaseal |
| Tactile Systems Technology INC | $33.95 | 2020 | |
| Mozarc Medical US LLC | $28.93 | 2023 | Argyle |
| Cormedix INC. | $25.99 | 2024 | Defencath |
| Advanced Oxygen Therapy INC. | $22.05 | 2024 | Topical Oxygen Chamber For Extremities |
| Polynovo North America LLC | $19.54 | 2025 | Novosorb Btm |
| Heron Therapeutics, INC. | $16.81 | 2022 | |
| Cook Medical LLC | $15.57 | 2023 | Zilver Ptx |
| Reprise Biomedical, INC. | $15.55 | 2023 | Miro3d, Miroderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kulbaski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.